From all our results and on the basis of the molecular profiling established by Verhaak et al. [6,42] and on the new WHO classification [43], the R2J cell line could be classified into the mesenchymal-like subtype into the isocitrate deshydrogenase IDH-wildtype glioma subgroup. The gene discussed is IDH1; the disease is central nervous system cancer.